- Home
- LVO vs SCLX Comparison
LVO vs SCLX Comparison
Compare LVO & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVO
- SCLX
- Stock Information
- Founded
- LVO 2009
- SCLX 2011
- Country
- LVO United States
- SCLX United States
- Employees
- LVO N/A
- SCLX N/A
- Industry
- LVO Restaurants
- SCLX Biotechnology: Pharmaceutical Preparations
- Sector
- LVO Consumer Discretionary
- SCLX Health Care
- Exchange
- LVO Nasdaq
- SCLX Nasdaq
- Market Cap
- LVO 75.7M
- SCLX 81.7M
- IPO Year
- LVO N/A
- SCLX N/A
- Fundamental
- Price
- LVO $1.10
- SCLX $0.48
- Analyst Decision
- LVO Strong Buy
- SCLX Strong Buy
- Analyst Count
- LVO 2
- SCLX 3
- Target Price
- LVO $2.75
- SCLX $11.33
- AVG Volume (30 Days)
- LVO 309.3K
- SCLX 184.3K
- Earning Date
- LVO 02-06-2025
- SCLX 12-31-2024
- Dividend Yield
- LVO N/A
- SCLX N/A
- EPS Growth
- LVO N/A
- SCLX N/A
- EPS
- LVO N/A
- SCLX N/A
- Revenue
- LVO $127,817,000.00
- SCLX $50,833,000.00
- Revenue This Year
- LVO $7.88
- SCLX $32.77
- Revenue Next Year
- LVO $6.34
- SCLX $50.71
- P/E Ratio
- LVO N/A
- SCLX N/A
- Revenue Growth
- LVO 17.10
- SCLX 9.41
- 52 Week Low
- LVO $0.56
- SCLX $0.44
- 52 Week High
- LVO $2.15
- SCLX $2.63
- Technical
- Relative Strength Index (RSI)
- LVO 58.75
- SCLX 33.34
- Support Level
- LVO $0.96
- SCLX $0.48
- Resistance Level
- LVO $1.21
- SCLX $0.54
- Average True Range (ATR)
- LVO 0.09
- SCLX 0.06
- MACD
- LVO -0.00
- SCLX -0.00
- Stochastic Oscillator
- LVO 49.18
- SCLX 4.53
About LVO LiveOne Inc.
LiveOne Inc, formerly LiveXLive Media Inc is a premium internet network devoted to live music and music-related video content. The company has been building an online destination for music fans to enjoy live performances from music venues and music festivals around the world, such as Rock in Rio, Outside Lands Music and Arts Festival, and Hangout Music Festival, as well as original content, artist exclusives, and industry interviews. The Company operates mainly through three segments, PodcastOne, Slacker, and Media Group, with a majority of its revenue derived from the Slacker segment.
About SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.